Cocktail of MACC-1, Kisspeptin-1 and ALDH-1 Immunohistochemistry Biomarkers with Potential of Prognostication and Risk Stratification in Colorectal Carcinomas
DOI:
https://doi.org/10.21276/apalm.3642Keywords:
biomarkers, colorectal carcinoma, immunohistochemistry, metastasisAbstract
Background: Metastasis Associated in Colon Cancer gene has emerged as regulator of epithelial mesenchymal transition and is associated with poor prognosis. Kisspeptin 1, tumor suppressor enzyme affects cellular motility, tumor invasion and metastasis. Its reduced expression implies tumor progression and poor prognosis. ALDH1 gene is marker of stem cell activity. Its increased expression is a marker of tumor progression and resistance to chemotherapeutic drugs and radiation. These biomarkers can be detected by immunohistochemistry. The aim of our study is to find an association of MACC-1, KISS-1 and ALDH1 with aggressiveness and tumor progression in colorectal carcinomas. All retrospective and prospective cases of colorectal adenocarcinomas received over period of five years, from 2017 to 2021, were included in this study and case control study was planned.
Methods: The study population was divided into two comparison groups based on TNM staging: (a) those with non-aggressive tumors (controls) (TNM stage I, II) and (b) those with aggressive tumors (cases) (TNM stage III, IV). A total of 36 controls and 27 cases were studied. Immunohistochemistry for MACC-1, KISS-1 and ALDH1 was done. Cytoplasmic and membranous staining was considered positive for these three immunomarkers. Chi-square test was used to find out an association among these biomarkers and aggressiveness and tumor progression of colorectal carcinomas. P<0.05 was considered to be significant.
Results: We found an association of MACC1 and KISS1 with aggressiveness and tumor progression whereas no association could be established with ALDH1.
Conclusion: These biomarkers are promising targets for prognostication and developing novel anticancer therapeutics.
References
1. Mallath MK. Colorectal cancer screening: current status. Trop Gastroenterol 2014;35:1-4.
2. Meyer B, Are C. Current Status and Future Directions in Colorectal Cancer. Indian J Surg Oncol 2018:9:440-1.
3. Li H, Chen YX, Wen JG, Zhou HH. Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer. Oncol Lett 2017:14:3899-908.
4. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACCI, a newly identified key regulator of HGF-MET signaling. predicts colon cancer metastasis. Nat Med 2009:15:59-67.
5. Yu L, Zhu B, Wu S, Zhou L, Song W, Gong X, et al. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACCI in the prediction of metastasis and prognosis in ovarian carcinoma. Diagn Pathol 2017:12:23.
6. Babwah AV, Pampillo M, Min L, Kaiser UB, Bhattacharya M. Single-cell analyses reveal that KISS1R-expressing cells undergo sustained kisspeptin induced signaling that is dependent upon an influx of extracellular Ca2+. Endocrinology 2012 153:5875-87.
7. Chen S, Chen W, Zhan X, Lin S, Chen Z. Overexpression of KiSS-Ireduces colorectal cancer cell invasion by down regulating MMP-9 viablockingPI3K/Akt/NF-KB signal pathway. Int J Oncol 2016:48:1391-8.
8. Vassalli G. Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells. Stem Cells Int 2019;2019:3904645.
9. Chen J, Xia Q. Jiang B, Chang W, Yuan W, Ma Z, et al. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. PLoS One 2015;10:e0145164.
10. Januchowski R, Wojtowicz K, Zabel M. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Biomed Pharmacother 2013:67:669-80.
11. Zhu B, Zhou L, Yu L, Wu S, Song W, Gong X, et al. Evaluation of the correlation of vasculogenic mimicry, ALDHI, KAII and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma. BMC Surg 2017:17:47.
12. Zhu B, Wang Y, Wang X, Wu S, Zhou L, Gong X, et al. Evaluation of the correlation of MACCI, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma. Diagn Pathol 2018:13:45.
13. Koelzer VH, Herrmann P, Zlobec I, Karamitopoulou E, Lugli A, Stein U. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACCI) for survival prognosis of colorectal cancer patients: a retrospective cohort study. BMC Cancer 2015:15:160.
14. Holah NS, Aiad HA, Asaad NY, Elkhouly EA, Lasheen AG. Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study. J Clin Diagn Res 2017;11:17-23.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Gurpreet Kaur Walia, Prateek Kinra, Ramanjit Singh Akal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
